Machine Learning connects structure, bitterness & mechanism to antimalarial activity
Sambu, S.
Show abstract
Machine learning allows us to identify patterns we might otherwise have missed in the data. It therefore provides an ample solution to the age-old problem of lossless research. When the pattern is robust and the signal is durable, it is possible to use relatively modest amounts of data to build powerful well-learned models. By constructing a classifier using gradient-boosted machines, it was shown that the model was robust, yielded high quality metrics and demonstrated consistent probability assignments for chemistries that have a suitable chemical backbone qualified for inclusion in antiplasmodic libraries. Critical to model development was the utilization of molecular fingerprinting and extraction of physico-chemical parameters relevant to the mechanism driving antiplasmodic activity. Subsequently, such an approach allows the model to uncover the link between bitterness, molecular structure and therapeutic value. This approach to evaluating antiplasmodic activity in chemistries provides a low-cost tool usable in identifying new classes of molecules for use in reducing malaria morbidity that often affects vulnerable members of the community the most. Additionally, given their relatively broad, low colligation and potent efficacies, these molecules may provide strong safety margins and durability netting high returns for health equity.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 97%
- PharmaNet: Pharmaceutical discovery with deep recurrent neural networks. 95%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 95%
Similar papers in this journal
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 94%
- Primary Target Prediction of Bioactive Molecules from Chemical Structure 94%
- Evaluation of Host Defense Peptide (CaD23)-Antibiotic Interaction and Mechanism of Action: Insights from Experimental and Molecular Dynamics Simulations Studies 93%
Similar papers in this journal
- Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening 95%
- Retro Drug Design: From Target Properties to Molecular Structures 95%
- Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction 95%
Similar papers in this journal
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 96%
- Support Vector Machine based prediction models for drug repurposing and designing novel drugs for colorectal cancer 95%
- Machine learning approaches identify chemical features for stage-specific antimalarial compounds 95%
Similar papers in this journal
- Structure-Based Design of Small-Molecule Inhibitors of Human Interleukin-6 95%
- Identifying Protein Features and Pathways Responsible for Toxicity using Machine learning, CANDO, and Tox21 datasets: Implications for Predictive Toxicology 94%
- Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platform 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.